ScholarIQanswers from OpenAlex

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy

PaperCitations, authors & open-access status

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy have?

ScholarIQcitation count

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has 28 citations in the OpenAlex counts ScholarIQ stores.

When was GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy published?

ScholarIQyear

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has 2021 year in the ScholarIQ index.

What is the open-access status of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

ScholarIQoa status

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy has green oa status in the ScholarIQ index.

What is the DOI of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

ScholarIQdoi

The DOI for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

What is the PMID of GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

ScholarIQpmid

The PMID for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

What is the OpenAlex record for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy?

ScholarIQopenalex

The OpenAlex for GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial